title: Insulin degludec: a significant advancement in ultralong-acting Basal insulin.
abstract: This editorial discusses a novel basal insulin analog, insulin degludec. It describes the limitations of existing basal insulins, and builds the case for a better analog. The editorial discusses the evidence to support the efficacy, safety, tolerability, and flexibility of degludec, and assesses its utility as part of a person-centered approach to diabetes management.
authors.affiliation: Bharti Hospital and BRIDE, Karnal, India, brideknl@gmail.com.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kalra